The outlook of companies tied to blockbuster drugs like Viagra presents a complex investment picture. While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial wealth , the expiry in key territories has introduced considerable volatility. Investors are now grappling with the effect of rival medications